RXRX
Recursion Pharmaceuticals, Inc.
$3.32
+1.53%
2026-05-08
About Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States and the United Kingdom. The company develops REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-617, which is in Phase 1/2 clinical trial to treat advanced solid tumors; REC-1245, which is in Phase 1/2 clinical trial to treat biomarker-enriched solid tumors and lymphoma; REC-3565 that is in Phase 1/2 for the treatment of relapsed or refractory B-cell malignancies; and REC-4539, a reversible, CNS penetrant, orally bioavailable, and potential best-in-class inhibitor of LSD1 for the treatment of solid tumors and hematology oncology. Its preclinical stage product includes REC-7735 for the treatment of HR+ breast cancer; and REC-102 for the treatment of hypophosphatasia. The company has collaboration and agreement with Roche & Genentech; Sanofi; Bayer AG; Tempus; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Key Fundamentals
Forward P/E
-3.69
EPS (TTM)
$-1.16
ROE
-57.2%
Revenue Growth (YoY)
-56.1%
Profit Margin
0.0%
Debt/Equity
7.06
Price/Book
1.68
Market Cap
$1.72B
Avg Volume (10D)
12.0M
Recent Breakout Signals
No recent breakout signals detected for RXRX.
Recent Price Range (60 Days)
60D High
$4.08
60D Low
$2.80
Avg Volume
14.1M
Latest Close
$3.32
Get breakout alerts for RXRX
Sign up for Breakout Scanner to receive daily notifications when RXRX triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Recursion Pharmaceuticals, Inc. (RXRX) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors RXRX daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. RXRX operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.